WPD PHARMACEUTICALS

WPD is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. It operates its business primarily through WPD Poland, a subsidiary of and the operating branch of the Company. The Company owns approximately 7% of the outstanding shares of WPD Poland... WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) is a clinical-stage pharmaceutical company, with to focus on glioblastoma cancer ("GBM") and other brain tumour programs... WPD focuses on developing biological and chemical molecules involved in targeted therapy for brain glioma and other central nervous system cancers.

Also known as: WPD, WPD Pharmaceuticals Inc., WPD Pharmaceuticals Sp, WPD Poland

Primary location: Vancouver Canada